Finasteride and Its Intermediates en es it fr

Finasteride and Its Intermediates Brand names, Finasteride and Its Intermediates Analogs

Finasteride and Its Intermediates Brand Names Mixture

  • No information avaliable

Finasteride and Its Intermediates Chemical_Formula

C23H36N2O2

Finasteride and Its Intermediates RX_link

http://www.rxlist.com/cgi/generic3/propecia.htm

Finasteride and Its Intermediates fda sheet

Finasteride_and_Its_Intermediates FDA

Finasteride and Its Intermediates msds (material safety sheet)

Finasteride and Its Intermediates Synthesis Reference

No information avaliable

Finasteride and Its Intermediates Molecular Weight

372.544 g/mol

Finasteride and Its Intermediates Melting Point

252-254 oC

Finasteride and Its Intermediates H2O Solubility

11.7 mg/L

Finasteride and Its Intermediates State

Solid

Finasteride and Its Intermediates LogP

4.277

Finasteride and Its Intermediates Dosage Forms

Tablet

Finasteride and Its Intermediates Indication

For the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to: Improve symptoms, reduce the risk of acute urinary retention, reduce the risk of the need for surgery including transurethral resection of the prostat.

Finasteride and Its Intermediates Pharmacology

Finasteride is indicated for the treatment of male pattern hair loss (androgenetic alopecia) in men only. Finasteride is a competitive and specific inhibitor of Type II 5a-reductase, an intracellular enzyme that converts the androgen testosterone into DHT. Two distinct isozymes are found in mice, rats, monkeys, and humans: Type I and II. Each of these isozymes is differentially expressed in tissues and developmental stages. In humans, Type I 5a-reductase is predominant in the sebaceous glands of most regions of skin, including scalp, and liver. Type I 5a-reductase is responsible for approximately one-third of circulating DHT. The Type II 5a-reductase isozyme is primarily found in prostate, seminal vesicles, epididymides, and hair follicles as well as liver, and is responsible for two-thirds of circulating DHT.

Finasteride and Its Intermediates Absorption

No information avaliable

Finasteride and Its Intermediates side effects and Toxicity

No information avaliable

Finasteride and Its Intermediates Patient Information

No information avaliable

Finasteride and Its Intermediates Organisms Affected

Humans and other mammals